p62/SQSTM1 Cooperates with Hyperactive mTORC1 to Regulate Glutathione Production, Maintain Mitochondrial Integrity,

Hilaire C Lam1, Christian V Baglini1, Alicia Llorente Lope1

  • 1Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Cancer Research
|May 18, 2017
PubMed

Insights

p62 protein is crucial for kidney tumor development in TSC2-deficient cells by maintaining glutathione levels and mitochondrial function. Its depletion protects against tumor growth and sensitizes cells to oxidative stress.

Area of Science:

  • Oncology
  • Cell Biology
  • Metabolism

Background:

  • p62/sequestosome-1 (SQSTM1) accumulates in cells with hyperactive mTORC1, common in kidney tumors with tuberous sclerosis complex (TSC) gene mutations.
  • p62 is an autophagic substrate and adaptor protein with a role in cellular signaling and stress response.

Purpose of the Study:

  • To investigate the role of p62 in TSC2-deficient renal tumorigenesis.
  • To elucidate the mechanisms by which p62 influences cellular metabolism and mitochondrial function in the context of TSC2 loss.

Main Methods:

  • Utilized genetically modified mouse models (Tsc2+/-, Tsc2f/f Ksp-CreERT2+ crossed with p62-/-).
  • Performed metabolic profiling, gene expression analysis, and mitochondrial function assays.
  • Assessed cellular responses to oxidative stress and glutathione biosynthesis inhibition.

Main Results:

  • p62 deficiency protected mice from TSC2-driven renal tumor development.
  • p62 depletion reduced intracellular glutamine, glutamate, and glutathione (GSH) by downregulating the glutamine transporter Slc1a5.
  • p62 attenuation impaired mitochondrial morphology, reduced membrane potential and respiration, and increased reactive oxygen species, effects rescued by GSH or Sod2.
  • p62-depleted Tsc2-null cells showed increased sensitivity to oxidative stress and GSH biosynthesis inhibition.

Conclusions:

  • p62 is a critical mediator of TSC2-driven renal tumorigenesis.
  • p62 maintains intracellular GSH pools, limiting mitochondrial dysfunction in mTORC1-hyperactive tumor cells.
  • p62 and redox homeostasis represent potential therapeutic targets for these tumors.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K